Sanli Pharmaceutical announced that the original “Concerted Action Agreement” between Zhang Hai, the controlling shareholder and actual controller of the company, and Yue Xin Pharmaceutical, the shareholder, expired on November 5, 2026, and the two parties renewed the agreement on November 6, 2026 for a period of 12 months. If there is disagreement, vote according to Zhang Hai's opinion. As of the disclosure date of the announcement, Zhang Hai and his co-actors held a total of 199,261,487 shares of the company, accounting for 49.34% of the total share capital. This renewal did not result in a change in the actual control of the company, and Zhang Hai is still the controlling shareholder and actual controller of the company.

Sanli Pharmaceutical announced that the original “Concerted Action Agreement” between Zhang Hai, the controlling shareholder and actual controller of the company, and Yue Xin Pharmaceutical, the shareholder, expired on November 5, 2026, and the two parties renewed the agreement on November 6, 2026 for a period of 12 months. If there is disagreement, vote according to Zhang Hai's opinion. As of the disclosure date of the announcement, Zhang Hai and his co-actors held a total of 199,261,487 shares of the company, accounting for 49.34% of the total share capital. This renewal did not result in a change in the actual control of the company, and Zhang Hai is still the controlling shareholder and actual controller of the company.